1. Home
  2. Browse
  3. Bone & Joint

Bone & Joint

286 - 300 of 449 Results
Sort Results:
Other: New Drug: Uloric (Febuxostat) April 2009
Article: ads promoting Savella (milnacipran) as the first drug approved ONLY for fibromyalgia March 2009
Article: osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis March 2009
Commentary: Summary of the Latest Guidelines on Bisphosphonate-Induced Osteonecrosis March 2009
Commentary: New Drug: Savella (Milnacipran) March 2009
Guideline: Management of fibromyalgia syndrome in adults (2009) March 2009
Guideline: Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: An advisory statement from theAmerican Dental Association Council on Scientific Affairs (2008) March 2009
Guideline: Canadian Consensus Practice Guidelines for Bisphosphonate Associated Osteonecrosis of the Jaw (2008) March 2009
Guideline: American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaw—2009 Update March 2009
Article: more aggressive use of disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis February 2009
Guideline: Use of Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis February 2009
Article: Bone loss due to long-term Depo-Provera may not be as much of a problem as the black box warning suggests December 2008
Article: whether glucosamine and chondroitin are effective for osteoarthritis November 2008
Guideline: Diagnosis and Management of Osteoporosis in Canada (2002) October 2008
Guideline: NAMS Position Statement on the Management of Osteoporosis in Postmenopausal Women (2010) October 2008